All In Biotech

Drug Trial Radar · NCT07392892

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

A PHASE 2/3 INTERVENTIONAL STUDY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY IN TREATMENT-NAÏVE PARTICIPANTS WITH LOCALLY ADVANCED OR METASTATIC GASTRIC, GASTROESOPHAGEAL JUNCTION, OR ESOPHAGEAL ADENOCARCINOMA

Last checked: Nov 20, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 840 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

840

Planned (sponsor's estimate)

Start

May 14, 2026

Primary completion

Jul 22, 2031

Study completion Jul 21, 2032

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Feb 6, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is being done to learn more about a new medicine called PF-08634404 and how well it works when given with chemotherapy to people with gastroesophageal cancer that is locally advanced (spread to nearby tissues) or has spread to other parts of the body. To join the study, participants must meet the following conditions: Be 18 years or older. Have locally advanced or metastatic gastric, gastroesophageal junction or esophageal adenocarcinoma Be treatment naïve for advanced or metastatic disease Be in good physical condition and have healthy organs based on medical tests. The study has two parts: * In the first part, researchers will check how safe the study medicine in combination with chemotherapy is and how well people respond to it. * In the second part, they will compare study medicine plus chemotherapy to another approved treatment (nivolumab plus chemotherapy) to see which works better. The treatment will be given in repeated time periods called cycles.

Conditions

  • Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma
  • Metastatic Gastric Cancer
  • Gastroesophageal Junction Cancer
  • Esophageal Adenocarcinoma

Interventions

  • PF-08634404Biological

    Participants will receive PF-08634404 intravenously.

  • ChemotherapyDrug

    Participants will receive PF-08634404 intravenously in combination with Chemotherapy.

  • NivolumabBiological

    Participants will receive Nivolumab intravenously.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Phase 2: Confirmed Objective response rate (ORR) using RECIST 1.1 as assessed by investigatorTime frame: Approximately 4 years
  2. Phase 2: Number of participants with treatment-emergent adverse eventsTime frame: Through 90 days after the last study intervention; Approximately 4 years
  3. Phase 3: Progression Free Survival (PFS) using RECIST 1.1 as assessed by BICRTime frame: Approximately 4 years
  4. Phase 3: Overall Survival (OS)Time frame: Approximately 4 years

Locations

102 sites in 10 countries. Site status is shown where the registry gives one.

  • UCLA Hematology/Oncology - Atascadero

    Atascadero, California · Recruiting

  • UCLA Hematology/Oncology - Burbank

    Burbank, California · Recruiting

  • UCLA Hematology/Oncology - Encino

    Encino, California · Recruiting

  • UCLA Hematology/Oncology - Marina del Rey

    Marina del Rey, California · Recruiting

  • UCLA Hematology/Oncology - Porter Ranch

    Porter Ranch, California · Recruiting

  • UCSF Helen Diller Family Comprehensive Cancer Center

    San Francisco, California · Not yet recruiting

  • UCSF Investigational Drugs Pharmacy

    San Francisco, California · Not yet recruiting

  • UCLA Hematology/Oncology - San Luis Obispo

    San Luis Obispo, California · Recruiting

  • UCLA Hematology/Oncology - Santa Barbara

    Santa Barbara, California · Recruiting

  • UCLA Hematology/Oncology - Santa Monica

    Santa Monica, California · Recruiting

  • Rocky Mountain Cancer Centers, LLP

    Aurora, Colorado · Recruiting

  • Rocky Mountain Cancer Centers, LLP

    Boulder, Colorado · Recruiting

  • Rocky Mountain Cancer Centers, LLP

    Centennial, Colorado · Recruiting

  • Rocky Mountain Cancer Centers, LLP

    Colorado Springs, Colorado · Recruiting

  • Rocky Mountain Cancer Centers, LLP

    Colorado Springs, Colorado · Recruiting

  • Rocky Mountain Cancer Centers, LLP

    Denver, Colorado · Recruiting

  • Rocky Mountain Cancer Centers, LLP

    Denver, Colorado · Recruiting

  • Rocky Mountain Cancer Centers, LLP

    Englewood, Colorado · Recruiting

  • Rocky Mountain Cancer Centers, LLP

    Lakewood, Colorado · Recruiting

  • Rocky Mountain Cancer Centers, LLP

    Littleton, Colorado · Recruiting

  • Rocky Mountain Cancer Centers, LLP

    Lone Tree, Colorado · Recruiting

  • Rocky Mountain Cancer Centers, LLP

    Longmont, Colorado · Recruiting

  • Rocky Mountain Cancer Centers, LLP

    Pueblo, Colorado · Recruiting

  • Rocky Mountain Cancer Centers, LLP

    Thornton, Colorado · Recruiting

  • Florida Cancer Specialists

    Daytona Beach, Florida · Not yet recruiting

  • Florida Cancer Specialists

    Fleming Island, Florida · Not yet recruiting

  • Florida Cancer Specialists

    Palm Beach Gardens, Florida · Not yet recruiting

  • Florida Cancer Specialists

    Sebring, Florida · Not yet recruiting

  • Florida Cancer Specialists

    Wellington, Florida · Not yet recruiting

  • Florida Cancer Specialists

    West Palm Beach, Florida · Not yet recruiting

  • Illinois Cancer Specialists

    Arlington Heights, Illinois · Recruiting

  • Illinois CancerCare - Bloomington

    Bloomington, Illinois · Recruiting

  • Illinois Cancer Specialists

    Chicago, Illinois · Recruiting

  • Illinois CancerCare - Galesburg

    Galesburg, Illinois · Recruiting

  • Illinois Cancer Specialists

    Niles, Illinois · Recruiting

  • Illinois CancerCare-Ottawa-Fox River Cancer Center

    Ottawa, Illinois · Recruiting

  • Illinois CancerCare-Pekin

    Pekin, Illinois · Recruiting

  • Illinois CancerCare, P.C.

    Peoria, Illinois · Recruiting

  • Illinois CancerCare-Peru - Valley Regional Cancer Center

    Peru, Illinois · Recruiting

  • Illinois CancerCare-Washington

    Washington, Illinois · Recruiting

Showing 40 of 102 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.